Spikevax is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Moderna Us, Inc.. The primary component is Elasomeran.
| Product ID | 80777-100_8483facf-1d72-4de3-ac81-eedc517bac1b | 
| NDC | 80777-100 | 
| Product Type | Vaccine | 
| Proprietary Name | Spikevax | 
| Generic Name | Covid-19 Vaccine, Mrna | 
| Dosage Form | Injection, Suspension | 
| Route of Administration | INTRAMUSCULAR | 
| Marketing Start Date | 2022-04-01 | 
| Marketing Category | BLA / | 
| Application Number | BLA125752 | 
| Labeler Name | Moderna US, Inc. | 
| Substance Name | ELASOMERAN | 
| Active Ingredient Strength | 0 mg/mL | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2023-12-31 | 
| Marketing Start Date | 2022-04-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 61434-043 | SPIKEVAX | COVID-19 Vaccine, mRNA | 
| 80777-100 | Spikevax | COVID-19 Vaccine, mRNA | 
| 0069-2025 | Comirnaty | COVID-19 Vaccine, mRNA | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  SPIKEVAX  97037862  not registered Live/Pending | ModernaTx, Inc. 2021-09-21 | 
|  SPIKEVAX  90247367  not registered Live/Pending | ModernaTx, Inc. 2020-10-11 |